The prevalence of AD worldwide is estimated to reach 131 million by 2050. Most disease-modifying treatments and drug trials have failed, due partly to the heterogeneous and complex nature of the disease.

Introduction: Aim of this study was identify the prevalence of frailty in patients with idiopathic Parkinson’s disease (PD), to describe the relationship between severity of the disease and frailty, and to evaluate if timed up and go (TUG) is an eligible test for determination of frailty in idiopathic PD patients. Methods: We conducted a cross-sectional study which included 66 patients, aged 60 and over in a tertiary hospital. Frailty was assessed by the Fried Frailty Index (FFI). Severity of the idiopathic PD was detected by the Hoehn and Yahr (H&Y) scale. Mobility was measured by the TUG test. Demographic characteristics and comprehensive geriatric assessments were evaluated. Descriptive statistics and logistic regression were used in analyses. Receiver operating characteristic (ROC) curves were used to identify the discriminative effect of TUG test on frailty. Results: The numbers of frail, prefrail, and robust subjects were 34 (51.5%), 24 (36.4%), and 8 (12.1%), respectively. Dependency in instrumental activities of daily living (IADL) was significantly associated with frailty (Odds ratio (OR): 36.00, Confidence interval (CI): 8.43–153.80). Multivariate logistic regression analysis results yielded, depression (OR: 10.37, CI: 2.82–38.12) and higher levodopa doses (OR: 6.28, CI: 1.77–22.24) were independently associated with frailty. TUG test performance was strongly associated with frailty with high sensitivity (0.806) and specificity (0.826) (Area under the curve (AUC): 0.831). Conclusions: Frailty is highly prevalent in idiopathic PD and is strongly associated with disabilities as well as specific risk factors of the disease. The TUG may be a reliable test for prediction of frailty in patients with idiopathic PD.

ObjectiveParkinson's Disease Caregivers (PDC) play an important role, especially in the medium and advanced phase of the disease for patients’ daily life activities, treatment, and follow‐up. The aim of this study is to attract attention to the factors which place PDC at risk of psychological problems and to give consideration to these factors.Materials and MethodsFirst of all, the 80 participants, who were PDC, filled in the demographic information form. The Hospital Anxiety and Depression Scale (HADS) was applied in order to determine the psychological status of the PDC.ResultsThe average age of PDC in the study was found as 47.94. While 11 (13.8%) of the PDC had undergone psychiatric treatment in the past, four of them (5%) were currently receiving treatment. Twenty‐eight (35%) of those who provide care have experience in patient care, whereas 52 (65%) of them have no prior experience in caring for patients. Thirty‐six (45%) of the PDC reported that they had difficulties, which were mostly psychological. According to the HADS which was applied, anxiety was seen in 26 of those who provide care (32.5%), while depression was seen in 41 (51.3%).ConclusionThis study is the first to provide data on the psychological status of PDC in our country. It is important that PDC's psychological problems are reduced by psychotherapy or, if necessary, by treatment. This situation has a direct negative effect on the patient's daily life activities.

Introduction: The main purpose of this research is develop the Turkish version of the BNT long form (consist of 60 items) [BNT-60 (TR)] and to determine the normative data for Turkish healthy geriatric population. BNT is a neuropsychological test which was widely used to measure naming disorders associated with a variety of neuropathological events. This research consists of two stages. In the stage of pilot study, adaptation of test was completed and BNT-60 (TR) version was developed; and in the stage of normative study, normative data was collected and norm determination was completed. Methods: Ninety healthy and volunteer elderly were participated in pilot study and 317 were in normative study. Three screening tests called Montreal Cognitive Assessment (MOCA), Functional Activities Questionnaire (FAQ) and Geriatric Depression Scale (GDS) were administered for participant selection. BNT-60 (TR) was applied to participants who meet the inclusion criteria. Results: According to 5 (age) x 2 (gender) x 3 (education) factorial ANOVA results, main effects of age and education level on BNT-60 (TR) total score were found statistically significant. Then according to MANOVA results, main effects of age and education level on BNT-60 (TR) sub-scores were found statistically significant. On the other hand, main effect of gender was not significant on BNT-60 (TR) scores. The age and BNT-60 (TR) total score were negatively correlated. This results consistent with other normative studies of BNT in the literature. Conclusion: Finally, BNT-60 (TR) is adopted for Turkish culture, determined normative data and a test which is evaluating naming ability of the older adults was put into use.

The differential diagnosis of young-onset progressive dementia is an issue that requires effort. Recording the family history and careful clinical evaluation are useful tools in the diagnosis. In case of genetic bases, definitive diagnosis requires molecular analysis. We report consanguineous two patients presenting with young-onset progressive dementia characterized by behavioral changes and with bone cysts. Concomitant bone pathology and inheritance pattern directed us to investigate gene, for differential diagnosis, which resulted with the identification of a causative mutation that confirmed the diagnosis of Nasu Hakola disease. The mutation (c.113A>G) is the same for a Turkish family with Nasu Hakola disease reported before. But the presence of bone cysts and absence of epilepsy in our patients are the different findings. Molecular analysis should be considered in patients with young age onset behavioral and cognitive deficits, with white matter lesions in brain magnetic resonance imaging, if especially associated with cystic bone lesions.